Abstract
Introduction
All persons are regularly exposed to radiation such as environmental radiation and radiation from industrial and medical sources. In the past 10 years, radiological examinations performed in pregnant women have increased by 107% and the greatest increase is seen in use of contrast enhanced computed tomography (CT). 1 Although ultrasonography (US) is the first preferred radiological examination in pregnant women, CT and magnetic resonance imaging (MRI) are occasionally required in some cases, and these examinations often require the intravenous injection of contrast media. Physicians should know about the potential effects of radiation and contrast media so as to provide appropriate management of pregnant women. 2 The aim of this study is to review the literature regarding prenatal radiation exposure and to discuss the types, effects and fetal risks of radiation.
Forms of radiation
Radiation, emitted as particles or waves is a kind of fast-moving energy which is classified as nonionizing and ionizing radiation. In nonionizing low-frequency radiation, energy is dispersed through heat and increased molecular movement; this includes visible light, ultraviolet rays, microwave, ultrasound, radio frequency and some electromagnetic waves. Ionizing radiation includes particles (alpha and beta particles) and electro-magnetic radiation (gamma rays and x-rays) and it can alter the normal structure of a living cell. 3 The average annual exposure of radiation from cosmic rays, radioactive substances in the environment and naturally occurring radiation in the human body is 1 mGy (0.1 rad). 4 Common medical applications of nonionizing and ionizing radiation are presented in Table 1 . 
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Non-ionizing radiation
Nonionizing radiation interacts with the tissue through the formation of heat. The effect of in utero exposure to nonionizing radiation has been evaluated, and no major risks have been detected. 5 The most common type of diagnostic nonionizing radiation performed in pregnant women is ultrasound. Previous studies reported that there is no relationship between prenatal US and adverse fetal effects such as childhood malignancies including mental retardation. 6 However, US has thermal tissue effects and it is advised to be performed using the lowest possible exposure setting under the ALARA (as low as reasonably achievable) principle. 7 MRI is another type of nonionizing radiation used in medicine. 2 The advantages of MRI are multiplanar capability and excellent evaluation of soft-tissue. 8 The risks of MRI in pregnant women have been evaluated with computer simulations and animal models. The risk to the fetus on 1.5-Tesla (The unit for the MRI systems that shows the strength of the magnetic field they produce. 1 Tesla=10,000 gauss, earth's magnetic field is 0.5 gauss) MRI appear to be nonsignificant. 9 However, the possible risks of MRI with higher field strength have not been extensively evaluated. In 2007, the American College of Radiology (ACR) guidelines for MRI recommended that MRI should be used when the risk-benefit ratio warrants the study. The heat of the magnetic field may cause a possible risk to the fetus, especially in the first trimester. 10 Another potential risk of MRI is that of acoustic injury. However, previous studies reported that this possible risk seems less likely, since sound is attenuated through amniotic fluid and it generally affects the fetus at a level of less than 30 dB. 10 In 1991, the Safety Committee of the Society of MRI stated that MRI may be performed in pregnant women when US is inadequate or insufficient. They also stated that pregnant women should be informed about the fact that MRI during pregnancy did not have any deleterious effects to date.
11,12
Ionizing Radiation
Ionizing radiation acts directly with the biochemical structures in tissue (including proteins, DNA, and other molecules) or indirectly by leading to the formation of free radicals. The effects of exposure may be classified under 2 types; deterministic and stochastic effects. 13 
Deterministic effects
Deterministic effects are caused by high exposure doses of radiation. These effects are predictable and involve multicellular injury, including chromosome aberrations.
14 The threshold dose for the evaluation of the pregnancy has been estimated to be 150 mGy (15 rad). 15 At this dose, it is recommended that the pregnancy should be evaluated for the need of intervention, such as termination of pregnancy. Theoretical risks at this dose include a less than 3% chance of cancer development, a 6% chance of mental retardation, loss of intelligence quotient (IQ) points by 30 points per 100 mGy,
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and a 15% chance of microcephaly. 13, 14 However, the risks depend on the timing and dose of the exposure in early gestation (Table 2) . 16 Although there is theoretical risk with any exposure to ionizing radiation, the dose exposed to the fetus from a single diagnostic examination is generally much less than 50 mGy (5 rad) which can be regarded as threshold value for noncancerous health effects of ionizing radiation. 
Stochastic effects
Stochastic effects are the result of cellular damage, presumably at the DNA level, that leads to cancer or other germ cell mutations. Stochastic effects have no threshold value and are thought to occur with any exposure dose of ionizing radiation. The severity of stochastic effects is independent of the radiation dose. The radiation dose estimated for stochastic effects was established at 50 mGy (5 rad). 10 It is considered that this level provides a margin of safety from higher exposures. 14, 19 It is reported that the risk of childhood cancer doubles with exposures over 50 mGy. 20 However, this value is not regarded as current in these days, since no radiation effects have been clearly reported at this level. In 2008, ACR provided guidelines for imaging in pregnant women and estimated fetal risk of various radiation exposure doses in various gestational ages [ Table 2 ]. 16 These values are provided from animal studies, epidemiological studies of survivors in Japan at the time of atomic bombings and studies of groups exposed to radiation for medical reasons such as radiation therapy for uterus carcinoma. 
Contrast media
Studies of iodinated low osmolality contrast media (LOCM) in diagnostic Xray and CT, and gadolinium-based contrast agents (GBCAs) in MRI in pregnancy have been limited, and their effects on the human embryo or fetus are imperfectly understood. The assumption is that all iodinated and gadolinium-based contrast media behave similarly crossing the bloodplacenta barrier into the fetus. 21 The agents will be excreted through the urine into the amniotic fluid which will then be swallowed by the fetus. 23 It is then possible that a small amount will be absorbed from the gut of the fetus with the additional swallowed gadoliniumbased contrast agents eliminated back into the amniotic fluid. There are no data available to assess the rate of clearance of contrast media from the amniotic fluid. 
Iodinated Low Osmolality Contrast Media (LOCM)
In-vivo tests in animals have shown no evidence of either mutagenic or teratogenic effects with LOCM. 8, 9 No adequate and well-controlled teratogenic studies of the effects of these media in pregnant women have been performed. The effects of LOCMs on fetal thyroid functions are crucial
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because the fetal thyroid plays an important role in the development of the central nervous system. 9 There have been rare reports of hypothyroidism developing in the newborn infant after the administration of iodinated contrast medium during pregnancy; however, this occurred only following amino fetography using fat-soluble iodinated contrast medium which was performed in the past to detect congenital malformations.
Intravenous (IV) administration of iodinated contrast media doesn't affect short-term neonatal thyroid stimulating hormone (TSH), likely because the overall amount of excess iodide in the fetal circulation is very small; however, the long term effects are unknown. 21 To date, there has been no documented case of neonatal hypothyroidism from the maternal intravascular injection of watersoluble iodinated contrast agents. 23 There have been no other adverse effects that have been reported in the fetus or neonate following administration of LOCM; however, information on this issue is inadequate. 21 
Gadolinium-based contrast agents (GBCAs)
To date, there have been no known adverse effects to the human fetus reported when clinically recommended dosages of GBCAs have been given to pregnant women. A single cohort study of 26 women exposed to gadolinium chelates during the first trimester pf pregnancy showed no evidence of teratogenesis or mutagenesis in their progeny. 24 However, no adequate and well-controlled teratogenic studies of the effects of these media in pregnant women have been performed. GBCAs nephrogenic systemic fibrosis (NSF) is a potential risk, but there are no known cases of NSF linked to the use of GBCAs in pregnant patients to date. Gadolinium chelates may accumulate in the amniotic fluid; therefore, there is the potential for dissociation of the toxic free gadolinium ion, conferring a potential risk for the development of NSF in the child or mother. Because the risk is unknown, it is generally recommended that gadolinium chelates not be used routinely in pregnant patients. 21 Since it is unclear how GBCAs will affect the fetus, they should be used only with caution, when their usage is considered critical and the potential benefits justify the potential risk to the unborn fetus. If a GBCA is to be used in a pregnant patient, one of the agents believed to be at low risk for the development of NSF 25 should be used at the lowest possible dose to achieve diagnostic results. In pregnant patients with severely impaired renal function, the same precautions should be used as in non-pregnant patients.
General Recommendation of the Committee on Drugs and Contrast Media
At the present time, the Committee on Drugs and Contrast Media recommends the following in patients in whom imaging studies are requested that may require the use of iodinated contrast media or gadolinium based contrast media. 21 A) The radiologist should confer with the referring physician and document the following in the radiology report or the patient's medical record:
1. That information requested from the CT or MRI study cannot be acquired without the use of IV contrast or by using other imaging methods.
2. The information needed affects the care of the patient and/or fetus during the pregnancy.
3. That the referring physician is of the opinion that it is not prudent to wait to obtain this information until after the patient is no longer pregnant.
B) It is recommended that both pregnant patients undergoing CT or MRI with contrast media and their referring physicians should indicate that they understand the potential risks and benefits of procedures to be performed, alternative diagnostic options available (if any), and that they wish to proceed.
Management of patients exposed to radiation during pregnancy
Although avoidance of exposure to ionizing radiation is preferable for pregnant women, exposure may occur in some situations such as medical necessity, unknown pregnancy at the time of diagnostic or therapeutic intervention and workplace exposure. When there is an exposure, the first step is to estimate the cumulative radiation dose to the fetus. Approximate fetal radiation doses for common radiological procedures are given in Table 3 . 2, 8, 17, 18 Complex calculations are required for internal radiation doses because substances needed for fetal growth and development such as iodine may concentrate in fetal tissue and radioactive substances may concentrate in maternal tissues surrounding the uterus. Once the fetal radiation dose is estimated, the potential health effects can be evaluated. Discussions with pregnant women should include the immediate and short-term risks to the fetus, as well as the estimated long-term risks to the fetus such as cancer. Thereafter, pregnant women should be counseled in a nondirective manner and encouraged to make an informed decision about pregnancy management. 26 All pregnant women are entitled to counseling before exposure to radiation. The extent of communication about the effects of radiation should be related to the level of risk. A detailed explanation should be provided if the anticipated fetal dose or actual exposure exceeds 10 mGy (1 rad). 4 Women should be counseled that diagnostic radiography during pregnancy is safe under most circumstances and radiation exposure from a single diagnostic imaging procedure has not been associated with an increase in fetal anomalies or pregnancy loss.
17
Exposure to a cumulative dose of less than 50 mGy that is approximately equivalent to the radiation dose of 500 chest radiographies or 100 abdominal CT scans has not been shown to affect pregnancy outcomes compared with control populations exposed to background radiation.
3,4
Conclusion
Pregnant women are at risk of being exposed to radiation caused by medical and environmental reasons. Nonionizing radiation and contrast media used in some radiological examinations are considered less risky than ionizing radiation; however, further studies are required to clearly evaluate the effects of nonionizing radiation and contrast media. Ionizing radiation has significant risks for the fetus including teratogenic, carcinogenic and mutagenic effects. Physicians should be especially aware of the risks of medical imaging modalities performed in pregnant women, ionizing radiation is more deleterious in the first trimester of pregnancy compared to other trimesters and its effects are associated with the level of exposure doses. Unlike carcinogenic effects which are independent of the dose, other effects of ionizing radiation have not been identified at any stage of gestation with less than 50 mGy (5 rad) exposure dose. Although a diagnostic radiography or single imaging procedure during pregnancy is generally not associated with an increase in fetal anomalies or pregnancy loss, physicians should be careful about medical imaging procedures. The use of imaging procedures such as US and MRI should be encouraged instead of imaging procedures with ionizing radiation.
